Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

4.710

-0.010 (-0.21%)

At close: Mar 10, 2026, 4:00 PM EDT

4.800

+0.090 (1.91%)

After-hours: Mar 10, 2026, 7:58 PM EDT

Arbutus Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	22.41	36.33	26.29	30.78	109.28	52.25
Short-Term Investments	71.29	86.29	99.72	116.14	46.04	71.02
Cash & Short-Term Investments	93.7	122.62	126	146.91	155.32	123.27
Cash Growth	-26.68%	-2.68%	-14.23%	-5.41%	26.00%	35.71%
Accounts Receivable	0.91	2.41	1.78	1.35	0.9	1.31
Other Current Assets	2.84	2.28	4.25	2.87	4.45	3.12
Total Current Assets	97.44	127.32	132.03	151.14	160.66	127.7
Net Property, Plant & Equipment	0.14	4.36	6.09	6.81	8.08	9.33
Long-Term Investments	-	-	6.28	37.36	35.69	-
Other Long-Term Assets	0.13	0.03	-	0.1	0.06	0.04
Total Assets	97.71	131.71	144.4	195.42	204.49	137.08
Accounts Payable	4.65	7.56	10.27	16.03	10.84	9.15
Current Portion of Leases	0.53	0.48	0.43	0.37	0.38	0.39
Unearned Revenue	-	7.57	11.79	16.46	-	-
Total Current Liabilities	5.18	15.62	22.49	32.86	11.22	9.54
Long-Term Leases	0.39	0.81	1.34	1.82	2.23	2.59
Other Long-Term Liabilities	14.74	17.92	14.55	23.9	21.59	22.98
Total Long-Term Liabilities	15.13	18.72	15.9	25.71	23.83	25.57
Total Liabilities	20.31	34.34	38.38	58.57	35.05	35.11
Preferred Stock	-	-	-	-	-	0.15
Common Stock	1,419	1,410	1,350	1,319	1,287	0.99
Additional Paid-in Capital	83.29	82.05	81.27	72.41	65.49	60.75
Accumulated Other Comprehensive Income	-48.13	-48.14	-48.42	-50.49	-48.34	-48.17
Retained Earnings	-1,376	-1,347	-1,277	-1,204	-1,134	-1,046
Shareholders' Equity	77.4	97.37	106.02	136.85	169.44	101.97
Total Liabilities & Equity	97.71	131.71	144.4	195.42	204.49	137.08
Total Debt	0.92	1.29	1.77	2.19	2.61	2.98
Net Cash (Debt)	92.78	121.33	124.24	144.73	152.7	120.29
Net Cash Growth	-23.53%	-2.33%	-14.16%	-5.22%	26.95%	37.51%
Net Cash Per Share	0.48	0.65	0.75	0.96	1.44	1.59
Book Value	77.4	97.37	106.02	136.85	169.44	101.97
Book Value Per Share	0.40	0.52	0.64	0.91	1.59	1.34
Tangible Book Value	77.4	97.37	106.02	136.85	169.44	101.97
Tangible Book Value Per Share	0.40	0.52	0.64	0.91	1.59	1.34

Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q